Vaxart, Inc. Employee Count
The employee counts Vaxart, Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2024-12-31: Employees (as filed) 105; Filing 2025-03-20; Lease expense per employee $76,723.81.
- 2023-12-31: Employees (as filed) 109; Filing 2024-03-14; Lease expense per employee $74,183.49.
- 2022-12-31: Employees (as filed) 164; Filing 2023-03-15; Lease expense per employee $36,018.29.
- 2021-12-31: Employees (as filed) 110; Filing 2022-02-24; Lease expense per employee $36,818.18.
- Available history
- 2021-12-31 to 2024-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2024-12-31 | 105 | 2025-03-20 | $76,723.81 total lease cost |
| 2023-12-31 | 109 | 2024-03-14 | $74,183.49 total lease cost |
| 2022-12-31 | 164 full-time | 2023-03-15 | $36,018.29 total lease cost |
| 2021-12-31 | 110 full-time | 2022-02-24 | $36,818.18 total lease cost |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |